Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2CNS 2Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Lung Neoplasms 2Cachexia 2Anorexia 2Weight Loss 1Pancreatic Neoplasms 1Mesothelioma, Malignant 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Body Weight 1

Interventions

Megestrol Acetate 2remune 1ostarine 1nabilone 1clazakizumab 1anamorelin 1Sodium Chloride 1Radiotherapy 1Omacor 1Melatonin 1Infliximab 1Ibuprofen 1Exercise 1Enteral Nutrition 1Docetaxel 1Deuterium Oxide 1Deuterium 1Clarithromycin 1Caseins 1Carnitine 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cachexia × Megestrol Acetate × Thoracic × Clear all
NCT00031785 2021-09-09

Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer

Wake Forest University Health Sciences

Phase 3 Completed
25 enrolled
Thoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00637728 2016-06-23

Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients

Par Pharmaceutical, Inc.

Phase 3 Terminated
5 enrolled 8 charts
GastrointestinalThoracic

Anorexia, Body Weight, Cachexia, Lung Neoplasms, Pancreatic Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡